Skip to main content
. 2018 Feb 2;13(2):e0192109. doi: 10.1371/journal.pone.0192109

Fig 4. Analyses of EBV positivity in 101 MS and 21 non-MS cases using PCR (440 samples) and EBER-in situ hybridization (615 samples).

Fig 4

By EBER-ISH 82% (83/101) of MS cases, but only 24% (5/21) of non-MS cases were EBV positive. By PCR, 64% (65/101) of MS and 24% (5/21) of non-MS cases were positive. Overall, 90% (91/101) of the MS cases were positive for EBV by EBER-ISH and/or PCR. The 5/21 non-MS cases positive by PCR were also positive by EBER-ISH.